Listen to our latest Investing Matters Podcast episode 'Uncovering opportunities with investment trusts' with The AIC's Richard Stone here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAlliance Pharma Regulatory News (APH)

Share Price Information for Alliance Pharma (APH)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 41.90
Bid: 41.60
Ask: 41.70
Change: 1.40 (3.46%)
Spread: 0.10 (0.24%)
Open: 40.00
High: 43.00
Low: 39.50
Prev. Close: 40.50
APH Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Major Interests in Shares

18 Mar 2010 15:33

RNS Number : 8185I
Alliance Pharma PLC
18 March 2010
 



For Immediate Release

18 March 2009

 

ALLIANCE PHARMA PLC

 Notification of Major Interests in Shares

 

 

1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached:

Alliance Pharma plc

2. Reason for the notification (please tick the appropriate box or boxes):

An acquisition or disposal of voting rights

YES

An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached

An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments

An event changing the breakdown of voting rights

Other (please specify):

3. Full name of person(s) subject to the notification obligation:

New City High Yield Fund Limited

4. Full name of shareholder(s)  (if different from 3.)

5. Date of the transaction and date on which the threshold is crossed or reached:

16 March 2010

6. Date on which issuer notified:

17 March 2010

7. Threshold(s) that is/are crossed or reached:

Below 3%

 

 

8. Notified details:

A: Voting rights attached to shares

Class/type of shares

if possible using the ISIN CODE

Situation previous to the triggering transaction

Resulting situation after the triggering transaction

Number of Shares

Number of Voting Rights

Number of shares

Number of voting rights

% of voting rights

Direct

Direct

Indirect

Direct

Indirect

Ordinary Shares GB0031030819

600,000

600,000

150,000

Below 3%

B: Qualifying Financial Instruments

Resulting situation after the triggering transaction

Type of financial instrument

Expiration date

Exercise/ Conversion Period

Number of voting rights that may be acquired if the instrument is exercised/ converted

% of voting rights

 

C: Financial Instruments with similar economic effect to Qualifying Financial Instruments

Resulting situation after the triggering transaction

Type of financial instrument

Exercise price

Expiration date

Exercise/ Conversion period

Number of voting rights instrument refers to

 

% of voting rights

 

Convertible Bond

(GB0033882423)

31/12/2013

31/12/2013

6,303,358

 

Nominal

Delta

Below 3%

Total (A+B+C)

Number of voting rights

Percentage of voting rights

6,453,358

Below 3%

 

9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable:

N/A

 

 

 

Proxy Voting:

10. Name of the proxy holder:

N/A

11. Number of voting rights proxy holder will cease to hold:

N/A

12. Date on which proxy holder will cease to hold voting rights:

N/A

13. Additional information:

Compliance Officer, New City Investment Managers

(FRN: 408091)

14. Contact name:

Kate Haswell

15. Contact telephone number:

020 7201 6900

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLLLFVEVLITLII
Date   Source Headline
11th Oct 200511:21 amRNSResults Notification
30th Sep 20057:03 amRNSMisoprostol Symposium
19th Sep 20057:02 amRNSAppointment
1st Aug 20057:00 amRNSNotification of Shares
29th Jul 20057:00 amRNSDistribution Agreement
13th Jul 200510:11 amRNSNotification of Shares
6th Jul 20057:00 amRNSPhase III Trials Approval
24th Jun 20057:00 amRNSNotice of Interests in Shares
21st Jun 200510:52 amRNSAGM Statement
17th May 20057:00 amRNSShare Purchase
16th May 200512:35 pmRNSDirector Share Dealing
12th May 20057:01 amRNSPreliminary Results
11th May 20059:55 amRNSShare Purchase
9th May 20057:00 amRNSCo-Promotion Agreement
26th Apr 20057:02 amRNSKey Management Appointments
30th Mar 20055:33 pmRNSHolding(s) in Company
16th Mar 20057:00 amRNSTrading Statement
28th Feb 200511:37 amRNSDirector Shareholding
11th Jan 20057:00 amRNSClinical Trial Commences

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.